ArticleBreast cancer research and treatment2016

A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression.

Nathalie Reix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.